Shares in Bio-Rad Slide 7.12 Percent on Declining Q2 Profit | GenomeWeb

NEW YORK, Aug. 5 (GenomeWeb News) - Shares in Bio-Rad slipped 7.12 percent, or $4.42, to $57.63 after the company posted a 9-percent decline in profit.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.